Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 32 Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 16 Small Cell Lung Carcinoma 11 Ovarian Neoplasms 11 Colorectal Neoplasms 11 Sarcoma 9 Lung Neoplasms 9 Nasopharyngeal Carcinoma 7 Neoplasms 6 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Head and Neck Neoplasms 5 Glioma 5 Esophageal Neoplasms 5 Cholangiocarcinoma 5 Recurrence 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Esophageal Squamous Cell Carcinoma 4 Biliary Tract Neoplasms 4 Advanced Gastric Cancer 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor 3 Neoplasm Metastasis 3 NSCLC 3 Melanoma 3 Gastrointestinal Neoplasms 3

Interventions

Radiofrequency Ablation 2 apatinib 1 Surgical Procedures, Operative 1 Drug Therapy 1 Biopsy 1 1-fluoro-2-nitro-4-azidobenzene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thyroid Diseases × apatinib × Clear all

NCT04180007 2019-11-27

APT-01

Nanjing First Hospital, Nanjing Medical University

Phase 2 Unknown

Neoplasm Metastasis, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡